Brief: Emmaus Life Sciences Reinforces Positive Outcomes Of Endari Clinical Trials, Including Efficacy Findings That Led To FDA Approval
24/09/2019 12:16
Sept 24 (Reuters) - Emmaus Life Sciences Inc EMMA.PK :
* EMMAUS LIFE SCIENCES REINFORCES POSITIVE OUTCOMES OF
ENDARI ®
CLINICAL TRIALS, INCLUDING EFFICACY FINDINGS THAT LED TO FDA
APPROVAL
Source text for Eikon: ID:nPn1qtlm2a
Further company coverage: EMMA.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns